Grace Therapeutics, Inc. (GRCE)
1.81
+0.03
(+1.69%)
USD |
NASDAQ |
Nov 06, 10:06
Grace Therapeutics Market Cap : 29.46M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 28.97M |
| November 04, 2026 | 29.46M |
| November 03, 2026 | 29.94M |
| November 02, 2026 | 29.46M |
| October 30, 2026 | 31.57M |
| October 29, 2026 | 31.57M |
| October 28, 2026 | 32.71M |
| October 27, 2026 | 30.43M |
| October 26, 2026 | 29.46M |
| October 23, 2026 | 31.41M |
| October 22, 2026 | 31.16M |
| October 21, 2026 | 32.06M |
| October 20, 2026 | 32.22M |
| October 19, 2026 | 30.60M |
| October 16, 2026 | 30.76M |
| October 15, 2026 | 31.73M |
| October 14, 2026 | 30.76M |
| October 13, 2026 | 32.39M |
| October 12, 2026 | 32.87M |
| October 09, 2026 | 33.85M |
| October 08, 2026 | 33.20M |
| October 07, 2026 | 34.18M |
| October 06, 2026 | 33.61M |
| October 05, 2026 | 33.52M |
| October 02, 2026 | 33.69M |
| Date | Value |
|---|---|
| October 01, 2026 | 33.20M |
| September 30, 2026 | 34.99M |
| September 29, 2026 | 34.34M |
| September 28, 2026 | 34.50M |
| September 25, 2026 | 34.50M |
| September 24, 2026 | 35.15M |
| September 23, 2026 | 34.50M |
| September 22, 2026 | 34.83M |
| September 21, 2026 | 34.18M |
| September 18, 2026 | 34.34M |
| September 17, 2026 | 34.66M |
| September 16, 2026 | 34.83M |
| September 15, 2026 | 36.29M |
| September 14, 2026 | 37.27M |
| September 11, 2026 | 36.13M |
| September 10, 2026 | 36.78M |
| September 09, 2026 | 34.83M |
| September 08, 2026 | 34.50M |
| September 04, 2026 | 34.18M |
| September 03, 2026 | 34.83M |
| September 02, 2026 | 34.83M |
| September 01, 2026 | 34.18M |
| August 31, 2026 | 34.66M |
| August 28, 2026 | 34.50M |
| August 27, 2026 | 35.15M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.616B |
| Corcept Therapeutics, Inc. | 8.091B |
| Veru, Inc. | 35.29M |
| Johnson & Johnson | 652.23B |
| Eli Lilly & Co. | 1.286T |
Market Cap Related Metrics
| PEG Ratio | -0.0351 |
| Price to Book Value | 0.6110 |
| Price | 1.81 |
| Earnings Yield | -65.38% |
| PEGY Ratio | -0.0351 |